Estrogen positive breast cancer recurrence during tamoxifen therapy: microdissected tumor - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS807

Estrogen positive breast cancer recurrence during tamoxifen therapy: microdissected tumor

Expression profiling of microdissected estrogen positive primary breast cancer tumors from 60 patients. Patients later treated with tamoxifen for 5 years, and tumors grouped according to whether cancer recurred. Results identify markers of disease-free survival that include HOXB13 and IL17BR.

Organism:: Homo sapiens

Type:: Expression profiling by array, log ratio, 2 disease state sets

Platform:: GPL1223
Series:: GSE1378
60 Samples

DataSet

Accession:: GDS807

ID:: 807

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Related DataSets for GEO Profiles (Select 6588521) (1)
GEO DataSets
Estrogen positive breast cancer recurrence during tamoxifen therapy: microdissec...
Estrogen positive breast cancer recurrence during tamoxifen therapy: microdissected tumor
Accession: GDS807

GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets